Ten Covid-19 vaccines could be available by the middle of 2021 if they win regulatory approval, but their inventors need patent protection, the head of the global pharmaceutical industry group said.
https://www.pharmalive.com/wp-content/uploads/2020/11/FDA-to-make-emergency-use-authorization-data-public-for-COVID-19-vaccines-Reuters-11-17-20.jpeg237370Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2020-11-27 11:43:322020-11-30 15:47:15Ten Covid-19 vaccines seen by mid-2021, head of global pharma group says